IL6 and Duchenne muscular dystrophy: We recently reported that the overexpression of the proinflammatory cytokine IL-6 in dystrophin-deficient mice (mdx/IL-6 model) is able to exacerbate the dystrophic muscle phenotype, fostering pathologic changes in skeletal muscle and closely approximating the disease progression of DMD patients [27, 28, 31].